BioPlus Acquisition Corp. (BIOS)
NASDAQ: BIOS
· Real-Time Price · USD
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 9:46 PM
BioPlus Acquisition Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.74M | 1.99M | 2.02M | 852.98K | 562.61K | 307.19K | n/a | n/a | n/a | n/a |
Gross Profit | -1.17M | -1.17M | -1.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -2.16M | -1.14M | -1.17M | -852.58K | -563.46K | -309.17K | -2.18K | -2.02K | -1.15K | -5 |
Interest Income | 7.96M | 5.72M | 3.17M | 1.28M | 325.71K | 45.37K | n/a | n/a | n/a | n/a |
Pretax Income | 5.8M | 4.58M | 2M | 421.91K | -238.1K | -264.16K | -2.17K | -2.02K | -1.15K | -5 |
Net Income | 5.8M | 4.58M | 2M | 421.91K | -238.1K | -264.16K | -2.17K | -2.02K | -1.15K | -5 |
Selling & General & Admin | 716.64K | -306.93K | -19 | 853.14K | 563.65K | 309.36K | 2.18K | 2.02K | 1.15K | 5.00 |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 991.64K | -31.93K | -19 | 853.14K | 563.65K | 309.36K | 2.18K | 2.02K | 1.15K | 5.00 |
Interest Expense | 1.14M | 1.14M | 1.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.16M | 1.14M | 1.17M | 853.14K | 563.65K | 309.36K | 2.18K | 2.02K | 1.15K | 5.00 |
Income Tax Expense | -1.28K | n/a | -307 | -297.51 | -298.39 | -299.53 | 7.47 | -2.02 | -1.14 | n/a |
Shares Outstanding (Basic) | 24.48M | 23.56M | 597.79M | 29.31M | 5.75M | 29.31M | 12.5K | 6.88M | 5.76M | 5K |
Shares Outstanding (Diluted) | 24.48M | 23.56M | 26.43M | 29.31M | 29.31M | 29.31M | 12.5K | 6.88M | 5.75M | 5K |
EPS (Basic) | 0.25 | 0.20 | 0.02 | 0.00 | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | 0.30 | 0.25 | 0.07 | 0.00 | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 | -0.00 |
EBITDA | -2.16M | -1.14M | -1.17M | -852.41K | -563.29K | -309.01K | -2.01K | -2.02K | -1.14K | n/a |
EBIT | -1.23M | -1.48M | -1.48M | -411.54K | -250.53K | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 508.96K | 472.94K | 491.82K | 245K | 218.79K | 133.87K | 128.62K | 57.23K | 56.35K | 55.21K |